Enveric Biosciences announces 1-for-15 reverse stock split effective Jan 27, 2025

Enveric Biosciences, Inc.

Shareholders approved reverse split at a special meeting on Jan 17, 2025; ratio range 1:10 to 1:100.
Board set ratio at 1-for-15; outstanding shares to reduce from ~10.4M to ~692,580.
No fractional shares; rounding up to next whole number; authorized shares remain 100M.
Trading symbol ENVB unchanged; new CUSIP 29405E 406; adjusted trading begins Jan 27.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.